Jiangsu Kanion Pharmaceutical ,Ltd. Receivables

Jiangsu Kanion Pharmaceutical ,Ltd. (600557.SS) currently reports a receivables of $800M as of June 2026. That compares with $830M in the prior-year period — down 3.6% year over year. Use the charts on this page to explore Jiangsu Kanion Pharmaceutical ,Ltd.'s receivables history and peer comparisons.

Jiangsu Kanion Pharmaceutical ,Ltd.'s receivables decreased from $830M to $800M — a 3.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jiangsu Kanion Pharmaceutical ,Ltd. reported $800M in receivables as of June 2026. That compares with $830M in the prior-year period — down 3.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $800M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jiangsu Kanion Pharmaceutical ,Ltd., and consider following 600557.SS for alerts when major investors trade the stock.